Global Cord Blood (CO) Stock Price, News & Analysis

Company Overview

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

Key Stats

• Today's Range: $1.05 to $1.50
• 50-Day Range: $1.25 to $2.99
• 52-Week Range: $2.03 to $5.50
• Volume: 1,413 shs
• Average Volume: 216,519 shs
• Market Capitalization: $127.63 million
• P/E Ratio: 1.64
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CO Stock Analysis - Frequently Asked Questions

How have CO shares performed this year?

Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CO shares have decreased by 13.9% and is now trading at $1.05.
View the best growth stocks for 2024 here.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) issued its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Cord Blood investors own include Micron Technology (MU), Dynavax Technologies (DVAX), AT&T (T), Vale (VALE), Cisco Systems (CSCO), Pfizer (PFE) and United Microelectronics (UMC).

Company Calendar

• Last Earnings: 6/26/2018
• Today: 12/18/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: N/A
• Current Symbol: NYSE:CO
• CUSIP: N/A
• CIK: 1467808
• Web: www.globalcordbloodcorp.com
• Phone: (523) 605-8180
• Fax: 852-3605-8181
• Employees: 1,202
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 1.64
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.24 billion
• Price / Sales: 0.10
• Cash Flow: $0.25 per share
• Price / Cash Flow: 4.19
• Book Value: $6.34 per share
• Price / Book: 0.17

Miscellaneous

• Outstanding Shares: 121,551,000
• Free Float: N/A
• Market Cap: $127.63 million
• Optionable: No Data
• Beta: 0.16